Side effects of atypical antipsychotic drugs

J Ananth, S Parameswaran… - Current pharmaceutical …, 2004 - ingentaconnect.com
Recently there has been increased concern over the side effects of the atypical antipsychotic
drugs, including diabetes, hyperlipidemia and obesity. The relationship between diabetes …

Remission in first-episode psychosis: predictor variables and symptom improvement patterns

R Emsley, PP Oosthuizen, M Kidd, L Koen… - Journal of Clinical …, 2006 - psychiatrist.com
Background: Previous attempts to identify clinically useful predictors of treatment outcome in
schizophrenia have been hampered by methodological inconsistencies, including a lack of …

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies

R Emsley, P Oosthuizen, L Koen, DJH Niehaus… - Clinical …, 2008 - Elsevier
Background: Few studies have compared long-acting injectable second-generation
antipsychotics with oral antipsychotics. Long-acting injectable antipsychotics—developed …

Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study

R Emsley, PP Oosthuizen, L Koen… - The journal of …, 2012 - legacy.psychiatrist.com
Objective: An unanswered question in the management of schizophrenia is how long
antipsychotic treatment should be continued after a single psychotic episode. In this study …

[引用][C] 非典型抗精神病药治疗精神分裂症的临床应用评价

黄继忠, 张明园 - 中国医院用药评价与分析, 2005

Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients

D Becker, O Liver, R Mester, M Rapoport… - Journal of Clinical …, 2003 - psychiatrist.com
Background: The hyperprolactinemia induced by conventional antipsychotics often leads to
osteoporosis. The commonly used atypical antipsychotics risperidone and olanzapine vary …

Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study

M Fikreyesus, M Soboka, GT Feyissa - BMC psychiatry, 2016 - Springer
Background Psychotic relapse leads to repeated hospitalization and negatively affects the
clinical prognosis of the patients. Information on prevalence of relapse among patients with …

Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind …

DEN Addington, C Pantelis, M Dineen… - Journal of clinical …, 2004 - psychiatrist.com
Background: More head-to-head comparisons of antipsychotics are needed to discern the
relative efficacy and safety profiles of these compounds. Thus, we compared ziprasidone …

Risperidone in the treatment of patients with delirium

E Parellada, I Baeza, J de Pablo… - Journal of Clinical …, 2004 - psychiatrist.com
Background: The aim of this study was to evaluate the efficacy and safety of risperidone in
the treatment of patients with delirium. Method: We conducted a prospective, multicenter …

Long-acting risperidone: a review of its use in schizophrenia

TS Harrison, KL Goa - CNS drugs, 2004 - Springer
Summary Abstract Long-acting risperidone (Risperdal Consta™) is a novel, intramuscular
formulation of the atypical antipsychotic risperidone, which has shown efficacy in the …